Red cell PMVs, plasma membrane-derived vesicles calling out for standards

Biochemical and Biophysical Research Communications

Volumn 399, Issue 4, 2010, Pages 465-469

  Hind, Elliott ^a   Heugh, Sheelagh ^a   Ansa Addo, Ephraim A ^a   Antwi Baffour, Samuel ^a   Lange, Sigrun ^b   Inal, Jameel ^a  

^a LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Plasma membrane derived vesicles; Red cell; Standardization

Indexed keywords

CITRIC ACID;

ATHEROSCLEROSIS; BETA THALASSEMIA; CENTRIFUGATION; CHRONIC KIDNEY FAILURE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE PRESERVATION; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MALARIA FALCIPARUM; MEDICAL RESEARCH; MEMBRANE VESICLE; MENINGOCOCCEMIA; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RED CELL PLASMA MEMBRANE DERIVED VESICLE; SCOTT SYNDROME; SHORT SURVEY; SICKLE CELL ANEMIA; STANDARDIZATION; CHEMISTRY; DISEASES; IMMUNOCHEMISTRY; MEMBRANE MICROPARTICLE; METABOLISM; PARTICLE SIZE; PHAGOCYTOSIS; STANDARDS; THROMBOCYTE;

PAPAYA MOSAIC VIRUS;

BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CENTRIFUGATION; DISEASE; ERYTHROCYTE MEMBRANE; HUMANS; IMMUNOCHEMISTRY; PARTICLE SIZE; PHAGOCYTOSIS;

EID: 77956242802     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.095     Document Type: Short Survey

References (45)

1. Toth B., Lok C.A., Boeing A., Diamant M., van der Post J.A., Friese K., Nieuwland R. Microparticles and exosomes: impact on normal and complicated pregnancy. Am. J. Reprod. Immunol. 2007, 58:389-402.
2. Shah M.D., Bergeron A.L., Jing-Fei D., López J.A. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 2008, 19:365-372.
3. Robert S., Poncelet P., Lacroix R., Arnaud L., Giraudo L., Hauchard A., Sampol J., Dignat-George F. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?. J. Thromb. Haemost. 2008, 7:190-197.
4. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in hemostasis and vascular medicine. J. Thromb. Haemost. 2009, 101:439-451.
5. Lawrie A.S., Harrison P., Cardigan R.A., Mackie I.J. The characterization and impact of microparticles on hemostasis within fresh-frozen plasma. Vox Sang. 2008, 95:197-204.
6. Antwi-Baffour S., Kholia S., Yushau Y.K.-D., Ansa-Addo E.A., Stratton D., Lange S., Inal J.M. Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells - possible role in SLE. Biochem. Biophys. Res. Commun. 2010, 10.1016/j.bbrc.2010.06.079.
7. Salzer U., Hinterdorfer P., Hunger U., Borken C., Prohaska R. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII) and sorcin. Blood 2002, 99:2569-2577.
8. Bucki R., Bachelot-Loza C., Zachowsk A., Giraud F., Sulpice J.-C. Calcium induces phospholipid redistribution and microvesicles release in human erythrocyte membranes by independent pathways. Biochemistry 1998, 37:15383-15391.
9. Willekens F.L., Were J.M., Kruist J.K., Roerdinkholder-Stoelwinder B., Groenen-Döpp Y.A., Van den Bos A.B., Bosman G.J., van Berkel T.J. Liver kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005, 105:2141-2145.
10. Rumsby M.G., Trotter J., Allan D., Michell R.H. Recovery of membrane micro-vesicles from human erythrocytes stored for transfusion: a mechanism for the erythrocyte discocyte-to-spherocyte shape transformation. Biochem. Soc. Trans. 1977, 5:126-128.
11. Knowles D.W., Tilley L., Mohandas N., Chasis J.A. Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting. Proc. Natl. Acad. Sci. USA 1997, 94:12969-12974.
12. Wagner G.M., Chiu D.T., Qju J.H., Heath R.H., Lubin B.H. Spectrin oxidation correlates with membrane vesiculation in stored RBCs. Blood 1987, 69:1777-1781.
13. Lutz H.U., Liu S.C., Palek J. Release of spectrin-free vesicles from human erythrocytes during ATP depletion. I. Characterization of spectrin-free vesicles. J. Cell Biol. 1977, 73:548-560.
14. van Beers E.J., Schaap M., Berckmans J., Nieuwland R., Sturk A., van Doormaal F.F., Meijers J.C., Biemond B.J. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94:1513-1519.
15. Dignat-George F., Freyssinet J.-M., Key N.S. Centrifugation is a crucial step impacting microparticle measurement. Platelets 2009, 20:225-226.
16. Enjeti A.K., Lincz L.F., Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin. Thromb. Hemost. 2007, 33:771-779.
17. Allan D., Michell R.H. Calcium ion-dependent diacylglycerol accumulation in erythrocytes is associated with microvesiculation but not with efflux of potassium ions. Biochem. J. 1977, 166:495-499.
18. Cole W.F., Rumsby M.G., Langster G.H., Tovey L.A. The release of erythrocyte membrane antigens to the plasma as membrane microvesicles during the storage of human blood for transfusion. Biochem. Soc. Trans. 1978, 6:1375-1378.
19. Card R.T., Mohandas N., Mollison P.L. Relationship of post-transfusion viability to deformability of stored red cells. Br J. Haematol. 1983, 53:237-240.
20. Greenwalt T.J. The how and why of exocytic vesicles. Transfusion 2006, 46:143-152.
21. Racek J., Herynková R., Holecek V., Jerábek Z., Sláma V. Influence of antioxidants on the quality of stored blood. Vox Sang. 1997, 72:6-19.
22. Oreskovic R.T., Dumaswala U.J., Greenwalt T.J. Expression of blood group antigens on red cell microvesicles. Transfusion 1992, 32:848-849.
23. Rubin O., Crettaz D., Canellini G., Tissot J.-D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang. 2008, 95:288-297.
24. Bevers E.M., Wiedmer T., Comfurius P., Shattil S.J., Weiss H.J., Zwaal R.F., Sims P.J. Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992, 79:380-388.
25. Toti F., Freyssinet J.M. An ABC for Scott syndrome?. Blood 2005, 106:396-397.
26. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J. Thromb. Haemost. 2003, 1:655-1662.
27. Horstman L.L., Jy W., Jimenez J.J., Bidot C., Ahn Y.S. New horizons in the analysis of circulating cell-derived microparticles. Keio J. Med. 2004, 53:210-230.
28. Liu R., Klich I., Ratajczak J., Ratajczak M.Z., Zuba-Surma E.K. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely 'mark' them as apoptotic. Eur. J. Haematol. 2009, 83:220-229.
29. Rozmyslowicz T., Majka M., Kijowski J., Murphy S.L., Conover D.O., Poncz M., Ratajczak J., Gaulton G.N., Ratajczak M.F. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003, 17:33-42.
30. Faure V., Dou L., Sabatier F., Cerini C., Sampol J., Berland Y., Brunet P., Dignat-George F. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J. Thromb. Haemost. 2005, 4:566-573.
31. Shet A.S. Characterizing blood microparticles: technical aspects and challenges. Vasc. Health Risk Manag. 2008, 4:769-774.
32. Pattanapanyasat K., Noulsri E., Fucharoen S., Lerdwana S., Lamchiagdhase P., Siritanaratkul N., Webster H.K. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clinical Cytom. 2004, 57:23-31.
33. Hugel B., Socié G., Vu T., Toti F., Gluckman E., Freyssinet J.M., Scrobohaci M.L. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999, 93:3451-3456.
34. Jy W., Horstmann L.L., Jimenez J.J., Ahn Y.S. Measuring circulating cell-derived microparticles. J. Thromb. Haemost. 2004, 2:1842-1843.
35. Gritters M M., Grooteman M.P., Schoorl M., Schoorl M., Bartels P.C., Scheffer P.G., Teerlink T., Schalkwijk C.G., Spreeuwenberg M., Nubé M.J. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol. Dial. Transplant. 2006, 21:153-159.
36. Allan D., Thomas P., Limbrick R. The isolation and characterization of 60nm vesicles ('nanovesicles') produced during ionophore A23187-induced budding of human erythrocytes. Biochem. J. 1980, 188:881-887.
37. Philippé J., De Logi E., Baele G. Comparison of five different citrated tubes and their in vitro effects on platelet activation. Clin. Chem. 2004, 50:656-658.
38. Nantakomol D., Imwong M., Soontarawirat I., Kotjanya D., Khakhai C., Ohashi J., Nuchnoi P. The absolute counting of red cell-derived microparticles with red cell bead by flow rate based assay. Cytometry B Clin. Cytom. 2009, 76:191-198.
39. Nantakomol D., Chimma P., Day N.P., Dondorp A.M., Combes V., Krudsood S., Looareesuwan S., White N.J., Pattanapanyasat K., Chotivanich K. Quantitation of cell-derived microparticles in plasma using flow rate based calibration. Southeast Asian J. Trop. Med. Public Health 2008, 39:146-153.
40. Boulanger C.M., Amabile N., Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006, 48:180-186.
41. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007, 21:157-171.
42. Berckmans R.J., Neiuwland R., Boeing A.N., Romijn F.P., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. J. Thromb. Hemost. 2001, 85:639-646.
43. Hron G., Kollars M., Weber H., Sagaster V., Quehenberger P., Eichinger S., Kyrle P.A., Weltermann A. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. J. Thromb. Haemost. 2007, 97:119-123.
44. Leroyer A.S., Isobe H., Lesèche G., Castier Y., Wassef M., Mallat Z., Binder B.R., Tedgui A., Boulanger C.M. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 2007, 49:772-777.
45. Nieuwland R., Berckmans R.J., McGregor S., Böing A.N., Romijn F.P., Westendorp R.G., Hack C.E., Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000, 95:930-935.